Skip to content

Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen Development

Identification and Verification of Candidate Genes Responsible for Optic Disc Drusen

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05736237
Acronym
GENODD
Enrollment
20
Registered
2023-02-21
Start date
2023-05-01
Completion date
2024-05-31
Last updated
2024-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optic Disk Drusen

Keywords

Optic disc drusen, Genetics

Brief summary

The goal of this observational study is to learn about the genetic background for the development of optic disc drusen. The main question is: • Can one or more candidate genes be found? Participants will have a blood sample taken and answer a questionnaire.

Detailed description

The study is an international collaboration between University of Utah, University of Sydney, University of Valladolid, and University of Copenhagen. Patients with Optic disc drusen from 15 known optic disc drusen-families from different countries (USA, Australia, Spain and Denmark) are participating in this study. Blood samples are drawn from each patient and their affected and unaffected family members, and DNA will be extracted. The investigators will do an Optical coherence tomography-scan (according to ODDS Consortium guidelines), and the participant will be asked to fill out the Visual Function Questionnaire (VFQ-25) including four additional questions about optic disc drusen. The etiology of optic disc drusen will be analyzed with a Whole Exome Sequencing (WES), with the use of Next Generation Sequencing (NGS). Prior to WES, all participants will receive genetic counseling by a consultant to ensure awareness of possible secondary genetic findings.

Interventions

GENETICWhole exome sequencing

With Next Generation Sequenzing

Sponsors

Copenhagen University Hospital at Herlev
Lead SponsorOTHER

Study design

Observational model
FAMILY_BASED
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Adult patients over the age of 18, who are capable of giving consent * Diagnosis of optic disc drusen and a minimum of 3 optic disc drusen-affected family members

Exclusion criteria

* Less than 3 affected family members * Under the age of 18 or mentally disabled

Design outcomes

Primary

MeasureTime frameDescription
Candidate gene2023-2024Genetics variants shared by the families will be compared with findings in the remaining families and identical genes will undergo further analysis.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026